TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo

Thomas G. McWilliams, Laura Howard, Sean Wyatt, Alun M. Davies (Lead / Corresponding author)

Research output: Contribution to journalArticle

4 Citations (Scopus)
65 Downloads (Pure)

Abstract

We have studied the role of the tumor necrosis factor superfamily member APRIL in the development of embryonic mouse midbrain dopaminergic neurons in vitro and in vivo. In culture, soluble APRIL enhanced axon growth during a window of development between E12 and E14 when nigrostriatal axons are growing to their targets in the striatum in vivo. April transcripts were detected in both the striatum and midbrain during this period and at later stages. The axon growth–enhancing effect of APRIL was similar to that of glial cell-derived neurotrophic factor (GDNF), but in contrast to GDNF, APRIL did not promote the survival of midbrain dopaminergic neurons. The effect of APRIL on axon growth was prevented by function-blocking antibodies to one of its receptors, BCMA (TNFRSF13A), but not by function-blocking antibodies to the other APRIL receptor, TACI (TNFRSF13B), suggesting that the effects of APRIL on axon growth are mediated by BCMA. In vivo, there was a significant reduction in the density of midbrain dopaminergic projections to the striatum in April −/− embryos compared with wild type littermates at E14. These findings demonstrate that APRIL is a physiologically relevant factor for the nigrostriatal projection. Given the importance of the degeneration of dopaminergic nigrostriatal connections in the pathogenesis and progression of Parkinson's disease, our findings contribute to our understanding of the factors that establish nigrostriatal integrity.

Original languageEnglish
Pages (from-to)97-103
Number of pages7
JournalExperimental Neurology
Volume298
Early online date11 Sep 2017
DOIs
Publication statusPublished - 1 Dec 2017

Fingerprint

Mesencephalon
Axons
Growth
Blocking Antibodies
Dopaminergic Neurons
Nerve Growth Factors
Neuroglia
Transmembrane Activator and CAML Interactor Protein
Embryonic Development
Parkinson Disease
Embryonic Structures
Tumor Necrosis Factor-alpha
bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine

Keywords

  • APRIL knockout mice
  • Axon growth
  • Midbrain dopaminergic neuron
  • Nigrostriatal projection
  • TNF superfamily

Cite this

McWilliams, Thomas G. ; Howard, Laura ; Wyatt, Sean ; Davies, Alun M. / TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo. In: Experimental Neurology. 2017 ; Vol. 298. pp. 97-103.
@article{5497880db4594c969ed4790113a3a58d,
title = "TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo",
abstract = "We have studied the role of the tumor necrosis factor superfamily member APRIL in the development of embryonic mouse midbrain dopaminergic neurons in vitro and in vivo. In culture, soluble APRIL enhanced axon growth during a window of development between E12 and E14 when nigrostriatal axons are growing to their targets in the striatum in vivo. April transcripts were detected in both the striatum and midbrain during this period and at later stages. The axon growth–enhancing effect of APRIL was similar to that of glial cell-derived neurotrophic factor (GDNF), but in contrast to GDNF, APRIL did not promote the survival of midbrain dopaminergic neurons. The effect of APRIL on axon growth was prevented by function-blocking antibodies to one of its receptors, BCMA (TNFRSF13A), but not by function-blocking antibodies to the other APRIL receptor, TACI (TNFRSF13B), suggesting that the effects of APRIL on axon growth are mediated by BCMA. In vivo, there was a significant reduction in the density of midbrain dopaminergic projections to the striatum in April −/− embryos compared with wild type littermates at E14. These findings demonstrate that APRIL is a physiologically relevant factor for the nigrostriatal projection. Given the importance of the degeneration of dopaminergic nigrostriatal connections in the pathogenesis and progression of Parkinson's disease, our findings contribute to our understanding of the factors that establish nigrostriatal integrity.",
keywords = "APRIL knockout mice, Axon growth, Midbrain dopaminergic neuron, Nigrostriatal projection, TNF superfamily",
author = "McWilliams, {Thomas G.} and Laura Howard and Sean Wyatt and Davies, {Alun M.}",
note = "This work was supported by grants 103852 and 086842 from the Wellcome Trust.",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.expneurol.2017.09.007",
language = "English",
volume = "298",
pages = "97--103",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Elsevier",

}

TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo. / McWilliams, Thomas G.; Howard, Laura; Wyatt, Sean; Davies, Alun M. (Lead / Corresponding author).

In: Experimental Neurology, Vol. 298, 01.12.2017, p. 97-103.

Research output: Contribution to journalArticle

TY - JOUR

T1 - TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo

AU - McWilliams, Thomas G.

AU - Howard, Laura

AU - Wyatt, Sean

AU - Davies, Alun M.

N1 - This work was supported by grants 103852 and 086842 from the Wellcome Trust.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - We have studied the role of the tumor necrosis factor superfamily member APRIL in the development of embryonic mouse midbrain dopaminergic neurons in vitro and in vivo. In culture, soluble APRIL enhanced axon growth during a window of development between E12 and E14 when nigrostriatal axons are growing to their targets in the striatum in vivo. April transcripts were detected in both the striatum and midbrain during this period and at later stages. The axon growth–enhancing effect of APRIL was similar to that of glial cell-derived neurotrophic factor (GDNF), but in contrast to GDNF, APRIL did not promote the survival of midbrain dopaminergic neurons. The effect of APRIL on axon growth was prevented by function-blocking antibodies to one of its receptors, BCMA (TNFRSF13A), but not by function-blocking antibodies to the other APRIL receptor, TACI (TNFRSF13B), suggesting that the effects of APRIL on axon growth are mediated by BCMA. In vivo, there was a significant reduction in the density of midbrain dopaminergic projections to the striatum in April −/− embryos compared with wild type littermates at E14. These findings demonstrate that APRIL is a physiologically relevant factor for the nigrostriatal projection. Given the importance of the degeneration of dopaminergic nigrostriatal connections in the pathogenesis and progression of Parkinson's disease, our findings contribute to our understanding of the factors that establish nigrostriatal integrity.

AB - We have studied the role of the tumor necrosis factor superfamily member APRIL in the development of embryonic mouse midbrain dopaminergic neurons in vitro and in vivo. In culture, soluble APRIL enhanced axon growth during a window of development between E12 and E14 when nigrostriatal axons are growing to their targets in the striatum in vivo. April transcripts were detected in both the striatum and midbrain during this period and at later stages. The axon growth–enhancing effect of APRIL was similar to that of glial cell-derived neurotrophic factor (GDNF), but in contrast to GDNF, APRIL did not promote the survival of midbrain dopaminergic neurons. The effect of APRIL on axon growth was prevented by function-blocking antibodies to one of its receptors, BCMA (TNFRSF13A), but not by function-blocking antibodies to the other APRIL receptor, TACI (TNFRSF13B), suggesting that the effects of APRIL on axon growth are mediated by BCMA. In vivo, there was a significant reduction in the density of midbrain dopaminergic projections to the striatum in April −/− embryos compared with wild type littermates at E14. These findings demonstrate that APRIL is a physiologically relevant factor for the nigrostriatal projection. Given the importance of the degeneration of dopaminergic nigrostriatal connections in the pathogenesis and progression of Parkinson's disease, our findings contribute to our understanding of the factors that establish nigrostriatal integrity.

KW - APRIL knockout mice

KW - Axon growth

KW - Midbrain dopaminergic neuron

KW - Nigrostriatal projection

KW - TNF superfamily

U2 - 10.1016/j.expneurol.2017.09.007

DO - 10.1016/j.expneurol.2017.09.007

M3 - Article

VL - 298

SP - 97

EP - 103

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -